aibioCRON Cronos Group Inc.
Cronos Group (CRON) news
Cronos Group Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CRON, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Cronos Group news
We have not published a story on Cronos Group yet. When there is news, it will appear here.
Cronos Group annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $146.6 million | $117.6 million |
| Research and development | $4.4 million | $4.2 million |
| Net income (loss) | -$9.4 million | $41.1 million |
| Cash from operations | $25.9 million | $18.8 million |
| Cash and equivalents | $791.8 million | $858.8 million |
| Short-term investments | $40.0 million | $0 |
Questions about Cronos Group
What is the ticker symbol of Cronos Group?
Cronos Group Inc. trades under the ticker CRON on NASDAQ.
Where is Cronos Group listed?
Cronos Group Inc. is listed on NASDAQ.
Which country or territory is Cronos Group listed under?
Our directory records Cronos Group Inc. under United States.
Does aibio.space cover Cronos Group?
aibio.space lists Cronos Group Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
What was Cronos Group's revenue last year?
$146.6 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Cronos Group profitable?
Cronos Group Inc. reported a net loss of $9.4 million for the fiscal year ended Dec 31, 2025, and generated $25.9 million of cash from operations, per its annual report to the SEC.
How much does Cronos Group spend on research and development?
$4.4 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Cronos Group have?
$797.0 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Investor discussion: Cronos Group
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Mergers
Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 1.01,2.01,7.01,9.01). Source
Stock chart
Listing details
- Company
- Cronos Group Inc.
- Ticker
- CRON
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction